Surgery for Vocal Cord Paralysis
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00064571 |
Recruitment Status
:
Terminated
First Posted
: July 10, 2003
Last Update Posted
: April 24, 2006
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Unilateral vocal fold paralysis (UVFP) is caused by injury to the nerve to the affected vocal fold. The injury to the vocal fold makes the affected person's voice sound "breathy". Voice therapy is usually tried first, and, if unsuccessful, surgical treatment is considered. The standard surgical treatment is called vocal fold medialization and aims to bring the injured cord to the midline. An alternative surgical treatment, vocal fold reinnervation, aims to bring a new nerve supply to the injured vocal fold. The reinnervation operation, which has some potential advantages over the medialization operation also requires several months for final results to be gained. The goal of this multicenter, randomized clinical trial is to see which of the two surgical treatments produces a better outcome.
In order to participate in this study patients with UVFP must meet all entry criteria and must be released from voice therapy by a speech-language pathologist. Information collected for the study (pre-surgery, and at 6 and 12 months after surgery) includes voice recordings, movies made of vocal fold function, airflow and pressure measurements of the voicebox, and an outcomes questionnaire.
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Unilateral Vocal Cord Paralysis | Procedure: vocal fold medialization Procedure: vocal fold reinnervation | Phase 3 |
Unilateral vocal fold paralysis (UVFP) is caused by injury to the recurrent laryngeal nerve. Patients with UVFP may have significant impairment of vocal fold function, including a breathy paralytic dysphonia. There are several available approaches for the treatment of this condition. Vocal fold medialization is currently used by most otolaryngologists and is probably the standard of care for treating UVFP. An alternative approach is laryngeal reinnervation, which has a number of potential advantages over medialization but which requires several months before a final result is achieved. The primary goal of this multicenter, randomized clinical trial is to determine which approach produces a better outcome.
Patients with UVFP meeting all inclusion criteria and released from therapy by a speech-language pathologist will be randomized into either the medialization arm or the reinnervation arm. The data collection protocol consists of voice recordings, aerodynamic measurements, electroglottography, videostroboscopy, and a clinical outcomes questionnaire collected pre-treatment and at 6 and 12 months post-treatment.
Study Type : | Interventional (Clinical Trial) |
Enrollment : | 300 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Primary Purpose: | Treatment |
Official Title: | Medialization Vs Reinnervation for Vocal Cord Paralysis |
Study Start Date : | October 2002 |
Study Completion Date : | October 2005 |


Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Senior) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion criteria
- clinical diagnosis of unilateral vocal fold paralysis
- older than 18 years of age
- intact ansa cervicalis and recurrent laryngeal nerves
- life expectancy of greater than 2 years
- onset of the vocal fold paralysis within 2 years of the time of surgery
- no gelfoam injection for at least 4 months prior to initial data collection
- able to give informed consent
- willing and able to return for 6 and 12 month data collection sessions
- able and willing to perform questionnaire (by mail) 18 months after surgery
Exclusion criteria
- abnormal non-paralyzed fold
- other disorders affecting the larynx (voice box), such as multiple sclerosis, myasthenia gravis, spasmodic dysphonia, or essential voice tremor
- prior surgery to either vocal fold
- previous or planned irradiation of the voicebox

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00064571
United States, Alabama | |
University of Alabama-Birmingham | |
Birmingham, Alabama, United States | |
United States, California | |
UC-Irvine Medical Center | |
Irvine, California, United States | |
United States, District of Columbia | |
George Washington University | |
Washington, District of Columbia, United States | |
United States, Minnesota | |
University of Minnesota | |
Minneapolis, Minnesota, United States | |
United States, Missouri | |
Washington University | |
St. Louis, Missouri, United States, 63110 | |
United States, Ohio | |
University of Cincinnati | |
Cincinnati, Ohio, United States | |
Cleveland Clinic | |
Cleveland, Ohio, United States | |
United States, Oklahoma | |
University of Oklahoma | |
Oklahoma City, Oklahoma, United States | |
United States, Pennsylvania | |
Thomas Jefferson University | |
Philadelphia, Pennsylvania, United States | |
United States, Utah | |
University of Utah | |
Salt Lake City, Utah, United States | |
United States, Wisconsin | |
University of Wisconsin | |
Madison, Wisconsin, United States | |
Medical College of Wisconsin | |
Milwaukee, Wisconsin, United States |
Principal Investigator: | Randal C Paniello, MD | Washington University School of Medicine |
ClinicalTrials.gov Identifier: | NCT00064571 History of Changes |
Other Study ID Numbers: |
U01DC004681 ( U.S. NIH Grant/Contract ) |
First Posted: | July 10, 2003 Key Record Dates |
Last Update Posted: | April 24, 2006 |
Last Verified: | April 2006 |
Keywords provided by National Institute on Deafness and Other Communication Disorders (NIDCD):
unilateral vocal fold paralysis |
Additional relevant MeSH terms:
Paralysis Vocal Cord Paralysis Neurologic Manifestations Nervous System Diseases Signs and Symptoms |
Laryngeal Diseases Respiratory Tract Diseases Otorhinolaryngologic Diseases Vagus Nerve Diseases Cranial Nerve Diseases |